Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2000
06/28/2000EP1012275A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
06/28/2000EP1012256A2 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1011734A1 Gene therapy vehicle comprising dermal sheath tissue
06/28/2000EP1011733A1 Compositions and methods for enhancing delivery of therapeutic agents to cells
06/28/2000EP1011730A2 Targeted addition of soluble polymers to recombinant proteins
06/28/2000EP1011729A2 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
06/28/2000EP1011728A1 Prostaglandin product
06/28/2000EP1011727A1 Viscous hemostatic composition, in particular in gel state
06/28/2000EP1011722A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
06/28/2000EP1011721A1 Vaginal lactobacillus medicant
06/28/2000EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
06/28/2000EP1011705A2 Conjugates targeted to the interleukin-2 receptor
06/28/2000EP1011692A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
06/28/2000EP1011690A1 Cross-linked polysaccharide drug carrier
06/28/2000EP1011680A2 Controlled release microsphere delivery system
06/28/2000EP1011662A1 Improved compositions and methods for the control of smoking
06/28/2000EP1011644A1 Methods and apparatus for treatment of parkinson's disease
06/28/2000EP1011640A1 Solid pharmaceutical dosage forms in form of a particulate dispersion
06/28/2000EP1011639A1 Bright white film coatings and film coating compositions therefor
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP1011634A1 Preparation of pharmaceutical compositions
06/28/2000EP1011633A1 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
06/28/2000EP1011632A2 A pharmaceutical composition for treating dysmenorrhea and premature labor
06/28/2000EP1011610A1 Skin care compositions and use
06/28/2000EP1011609A1 Compositions for cosmetic applications
06/28/2000EP1011440A1 Vaccine against lipopolysaccharide core
06/28/2000EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000CN1258221A Biodegradable compositions comprising poly (cycloaliphatic phosphoester_ compounds, articles, and methods for using same
06/28/2000CN1258220A Pharmaceutical compositions comprising cyclodextrins
06/28/2000CN1258217A Pharmaceutical formulation of omeprazole
06/28/2000CN1258198A Utilisations of oil bodies
06/28/2000CN1257704A Submicro emulsion based on sugar fatty ester and sugar fatty ether, and use thereof
06/28/2000CN1053807C Vitamin E drop
06/27/2000US6080877 Taxanes
06/27/2000US6080793 Cosmetically/pharmaceutically/hygienically-active supple doughs comprising heat-sensitive compounds
06/27/2000US6080744 Topical antifungal treatment
06/27/2000US6080733 Thioureido-cyclodextrins, utilized in particular to solubilize anti-tumor, and antiparasitic agents and their preparation processes
06/27/2000US6080731 Dinucleoside-5', 5'-pyrophosphates administered to treat HIV
06/27/2000US6080725 Comprising one or more bacterial, viral or tumor-associated antigens; and one or more saponin-lipophile conjugate
06/27/2000US6080724 Peptides which can be used as vectors for the intracellular addressing of active molecules
06/27/2000US6080589 Neisseria meningitidis capsular polysacchride conjugates
06/27/2000US6080431 Nutritional mineral supplements comprising calcium citrate malate and vitamin d; for increasing bone growth and for treating age-related bone loss in humans and animals
06/27/2000US6080416 A hydroalcohol mixture of stearoxytrimethylsilane, cyclomethicone, cetyl lactate and a c1-15 alkyl lactate and ethyh, isopropyl and/or propyl alcohol and/or water; nontacky; moisturizing; protective coatings; skins
06/27/2000US6080397 Infusion or surgical rinse colloidal solutions of polyvinylpyrrolidone (pvp) of given molecular weight; free of impurities and high molecular weight pvp, and having low: amine content, peroxide, and solvent; nonallergenic
06/27/2000US6080395 Method and composition for topical treatment of damaged tissue using histamine as active ingredient
06/27/2000CA2131021C Use of injectable biomaterials for the repair and augmentation of the anal sphincters
06/24/2000CA2296193A1 Powdered dextrose and procedure for preparing it
06/22/2000WO2000036131A1 Synthetic nucleic acid particle
06/22/2000WO2000036094A1 Bleaching enzymes and detergent compositions comprising them
06/22/2000WO2000035990A1 Process for producing polymer
06/22/2000WO2000035861A1 Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
06/22/2000WO2000035487A1 Pharmaceutical conjugates comprising two active agents
06/22/2000WO2000035486A1 Soluble compositions of toremifene
06/22/2000WO2000035485A1 Soluble compositions of triphenylethylene antiestrogens
06/22/2000WO2000035460A2 Pharmaceutical formulations
06/22/2000WO2000035458A1 Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
06/22/2000WO2000035456A1 Transdermal delivery system containing buprenorphine
06/22/2000WO2000035445A1 Doramectin formulations
06/22/2000WO2000035441A2 Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
06/22/2000WO2000035439A1 The process for manufacturing formulation of topical beta blockers with improved efficacy
06/22/2000WO2000035437A2 Improving mental performance by increasing brain insulin sensitivity
06/22/2000WO2000035432A2 Improved viscoelastic compositions and methods of use
06/22/2000WO2000035423A1 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
06/22/2000WO2000035422A2 Method of administering a compound to multi-drug resistant cells
06/22/2000WO2000035419A2 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
06/22/2000WO2000035417A1 Pharmaceutical preparation for inhalation of an opioid
06/22/2000WO2000035357A1 Methods and apparatus for enhancement of transdermal transport
06/22/2000WO2000035289A1 Hydrogen peroxide disinfectant with increased activity
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000WO2000021504A8 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
06/22/2000WO2000012060A8 Electrically controlled transport of charged penetrants across barriers
06/22/2000WO2000010599A3 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
06/22/2000WO2000008004A8 Particle-forming compositions containing fused pyrrolocarbazoles
06/22/2000WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
06/22/2000WO1999066942A9 Compounds obtained from salvia species having antiviral activity
06/22/2000WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties
06/22/2000CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2355645A1 Increasing brain glucose utilization
06/22/2000CA2355276A1 Synthetic nucleic acid particle
06/22/2000CA2355184A1 Methods and apparatus for enhancement of transdermal transport
06/22/2000CA2354908A1 Bleaching enzymes and detergent compositions comprising them
06/22/2000CA2354765A1 The process for manufacturing formulation of topical beta blockers with improved efficacy
06/22/2000CA2353593A1 Method of administering a compound to multi-drug resistant cells
06/22/2000CA2352076A1 Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
06/21/2000EP1010708A1 New inverse latex stable against electrolytes, production process and use in cosmetics
06/21/2000EP1010423A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
06/21/2000EP1010414A1 Nanoemulsion based on mixed esters of a fatty acid or alcohol, of a carboxylic acid and glyceryl, and uses thereof in the cosmetical, dermatological and/or ophtalmological fields
06/21/2000EP1010413A1 Nanoemulsion based on fatty acid esters of sugar or fatty ethers of sugar and uses thereof in the cosmetical, dermatological and/or ophtalmological fields
06/21/2000EP1009847A1 Conjugates that contain the homeodomain of antennapedia
06/21/2000EP1009819A1 Methods using phage display for selecting internalizing ligands for gene delivery
06/21/2000EP1009715A1 Improved method for preparing low-concentration polyaluminosilicate microgels
06/21/2000EP1009524A1 Improvements in or relating to capsules
06/21/2000EP1009439A1 Polymer-platinum compounds
06/21/2000EP1009438A1 Dried biologically or therapeutically active preparations
06/21/2000EP1009437A1 Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
06/21/2000EP1009436A2 Acridine derivative for increasing the oral bioavailability of taxanes
06/21/2000EP1009434A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
1 ... 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 ... 1712